BCLI READ THE FULL BCLI RESEARCH REPORT Business Update Focused on Advancing NurOwn into Phase 3b ENDURANCE Trial BrainStorm ...

Amyotrophic Lateral Sclerosis Treatment Market Distribution Channel Insights Hospital pharmacies held a significant revenue share in the amyotrophic lateral sclerosis (ALS) treatment market in ...

It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...

In the beginning, not even Hynek Wichterle's postdoc thought his idea to slow the progression of amyotrophic lateral ...

A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...

Opinion: Claims of dramatic improvement or cures from ALS by unregulated clinics that seem too good to be true are likely ...

Certain subsets of microglia were found to be enriched in nervous system tissues from people with amyotrophic lateral ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that causes the gradual loss of motor neurons in the brain and spinal cord, leading to muscle weakness, paralysis, and ...

BOYNTON BEACH, Fla. — Boynton Beach Mayor Ty Penserga proclaimed Sept. 28 as ALS Awareness Day. Amyotrophic lateral sclerosis is a disease that attacks the nervous system, affecting nerve cells ...

The amyotrophic lateral sclerosis (ALS) treatment market was valued at USD 791.90 Million in 2024 and is projected to expand at a compound annual growth rate (CAGR) of 5.40% from 2025 to 2034.

The ALS treatment market, valued at USD 791.90 Million in 2024, is forecasted to grow at a CAGR of 5.40% from 2025 to 2034. Rising ALS prevalence, demand for treatments, and advancing research propel ...